Company News

Share this article:

Contract sales firm PDI announced new business wins exceeding $18 million, but would not divulge the new clients' names, based on contractual agreements, according to a spokesperson. The contracts include primary care, specialty and hospital settings sales teams, according to a statement. Reps will be deployed in June, and will call on hospital-based physicians specializing in women's health, primary care and pediatrics.

 

Eloquest Healthcare, a dermatology specialty company, partnered with Onset Therapeutics to market Optase, a topical prescription product for the treatment of decubitus ulcers, varicose ulcers and dehiscent wounds. Optase is one of two products joint-marketed by Onset Therapeutics and Eloquest Healthcare – the second is Exactacain, a topical anesthetic spray.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.